Biochemical markers in bronchial carcinoma

Area of Science:

• Oncology
• Biochemistry

Background:

• Bronchial carcinoma recurrence detection is crucial for effective patient management.
• Identifying reliable circulating tumor markers can improve early diagnosis and treatment monitoring.

Purpose of the Study:

• To investigate the utility of plasma carcinoembryonic antigen (CEA), calcitonin (CT), and parathyroid hormone (PTH) as potential biomarkers for bronchial carcinoma recurrence.
• To assess the correlation between elevated marker levels and tumor characteristics, particularly in oat-cell carcinoma.

Main Methods:

• Blood samples from 107 patients with bronchial carcinoma were analyzed for plasma CEA levels.
• Plasma CT and PTH levels were measured in a subset of 66 patients.
• Longitudinal monitoring of marker levels was performed.

Main Results:

• Elevated CEA levels (>40 microgram/l) were observed in 40.6% of patients, and elevated CT levels in 75% of patients with oat-cell tumors.
• Longitudinal studies suggest that persistently elevated marker levels can indicate recurrence when other clinical signs are absent.

Conclusions:

• No single ideal tumor marker for bronchial carcinoma was identified.
• Abnormal levels of CEA and CT, especially in oat-cell carcinoma, can serve as valuable indicators of recurrence and aid in guiding therapy.